Mass. Movers

Heart device maker slumps as profit falls

Abiomed’s AbioCor Total Replacement Heart.

Abiomed’s AbioCor Total Replacement Heart.

Shares of the medical device maker Abiomed Inc. fell sharply after the Danvers company reported lower profit in the third quarter, despite posting strong sales growth. Abiomed reported third-quarter fiscal 2013 revenue of $38.3 million, up 19 percent, compared to $32.2 million in fiscal 2012, on record quarterly patient product usage. Abiomed also reported net income of $2.7 million, or 7 cents a share, compared to net income of $2.9 million, 7 cents, in fiscal 2012.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of